Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

INNOVTEC stock news

This page provides real-time market news, earnings updates, and company announcements related to Innovative Tech Pack Limited (INNOVTEC).

All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.

Last updated as of 2026-02-19 18:47 IST

Sight Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 image

Sight Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026

Finviz2026-02-18 21:09:41
DoorDash reports robust quarterly increases in both sales and orders, yet cautions about significant expenses ahead image

DoorDash reports robust quarterly increases in both sales and orders, yet cautions about significant expenses ahead

101 finance2026-02-18 21:24:38
Jack in the Box (NASDAQ:JACK) Misses Q4 CY2025 Sales Expectations image

Jack in the Box (NASDAQ:JACK) Misses Q4 CY2025 Sales Expectations

Finviz2026-02-18 21:42:37
Bullish Analyst Opinion on Dyne (DYNE) Follows Rare Disease Drug Progress in Japan image

Bullish Analyst Opinion on Dyne (DYNE) Follows Rare Disease Drug Progress in Japan

Finviz2026-02-19 00:39:37
Jeffries Highlight Cybin D/B/A Helus Pharma (HELP)'s Science-Driven Psilocybin Therapies as Key Growth Drivers image

Jeffries Highlight Cybin D/B/A Helus Pharma (HELP)'s Science-Driven Psilocybin Therapies as Key Growth Drivers

Finviz2026-02-19 02:30:37
RBC Capital Cite GH Research PLC's (GHRS) Long-Term Sales Potential Following Psychedelics Symposium image

RBC Capital Cite GH Research PLC's (GHRS) Long-Term Sales Potential Following Psychedelics Symposium

Finviz2026-02-19 02:33:44
Needham Bullish on Neurocrine Biosciences, Inc. (NBIX) Pipeline Amid 2026 Growth Expectations for Crenessity and Ingrezza image

Needham Bullish on Neurocrine Biosciences, Inc. (NBIX) Pipeline Amid 2026 Growth Expectations for Crenessity and Ingrezza

Finviz2026-02-19 02:36:45
Teck Reports Unaudited Fourth Quarter Results for 2025 image

Teck Reports Unaudited Fourth Quarter Results for 2025

Finviz2026-02-19 06:06:04
5 Thought-Provoking Analyst Inquiries From Flowers Foods’s Fourth Quarter Earnings Discussion image

5 Thought-Provoking Analyst Inquiries From Flowers Foods’s Fourth Quarter Earnings Discussion

101 finance2026-02-19 10:03:37
5 Insightful Analyst Inquiries from Applied Materials’ Fourth Quarter Earnings Conference image

5 Insightful Analyst Inquiries from Applied Materials’ Fourth Quarter Earnings Conference

101 finance2026-02-19 10:18:41
Investment bank Piper Sandler recently announced its initial coverage of medical technology company Perspective Therapeutics (stock code: CATX), assigning an "Overweight" rating. image

Investment bank Piper Sandler recently announced its initial coverage of medical technology company Perspective Therapeutics (stock code: CATX), assigning an "Overweight" rating.

老虎证券2026-02-19 10:37:31
5 Thought-Provoking Analyst Inquiries from West Pharmaceutical Services’ Fourth Quarter Earnings Discussion image

5 Thought-Provoking Analyst Inquiries from West Pharmaceutical Services’ Fourth Quarter Earnings Discussion

101 finance2026-02-19 10:36:51
YETI Announces CFO Transition image

YETI Announces CFO Transition

Finviz2026-02-19 11:03:47
Madrigal Pharmaceuticals Reports Fourth-Quarter and Full-Year 2025 Financial Results image

Madrigal Pharmaceuticals Reports Fourth-Quarter and Full-Year 2025 Financial Results

Finviz2026-02-19 12:03:41
NovaBridge Appoints Biotech Leader, Emmett T. Cunningham, Jr, MD, PhD, MPH, as Vice Chairman of the Board to Further Accelerate Global Biotech Platform image

NovaBridge Appoints Biotech Leader, Emmett T. Cunningham, Jr, MD, PhD, MPH, as Vice Chairman of the Board to Further Accelerate Global Biotech Platform

Finviz2026-02-19 12:03:42
Regeneron Pharmaceuticals announced that its Biologics License Application (BLA) for Garetosmab, a treatment for fibrodysplasia ossificans progressiva (FOP), has been accepted by the U.S. Food and Drug Administration (FDA) and granted priority review status. image

Regeneron Pharmaceuticals announced that its Biologics License Application (BLA) for Garetosmab, a treatment for fibrodysplasia ossificans progressiva (FOP), has been accepted by the U.S. Food and Drug Administration (FDA) and granted priority review status.

老虎证券2026-02-19 12:11:51
Cardiff Oncology to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference image

Cardiff Oncology to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

Finviz2026-02-19 12:03:42
Jeffs' Brands: KeepZone AI Enters into Distribution Agreement with Assac Networks to Distribute Cybersecurity Software image

Jeffs' Brands: KeepZone AI Enters into Distribution Agreement with Assac Networks to Distribute Cybersecurity Software

Finviz2026-02-19 12:36:41
OSS Announces $10.5 Million in New Awards to Support U.S. Navy P-8A Poseidon Aircraft Program image

OSS Announces $10.5 Million in New Awards to Support U.S. Navy P-8A Poseidon Aircraft Program

Finviz2026-02-19 13:06:42
Artiva Biotherapeutics Announces Appointment of Elaine Sorg to Board of Directors image

Artiva Biotherapeutics Announces Appointment of Elaine Sorg to Board of Directors

Finviz2026-02-19 13:06:40

INNOVTEC stock price change

On the last trading day, INNOVTEC stock closed at 16.85 INR, with a price change of 4.27% for the day.

Trade stock futuresINNOVTEC stock details

About Bitget

The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more
INNOVTEC stock news